专利检索 ap:("Celgene Corporation") AND inv:"Jeffrey M. Schkeryantz" 第 1 页

1.

发明申请
Carboxylic Acid Containing Azetidinyl Compounds for the Treatment of Neurodegenerative Diseases 有权

公开(公告)号：US20230028747A1

公开(公告)日：2023-01-26

申请号：US17840876

申请日：2022-06-15

申请人： Celgene Corporation

发明人： Jeffrey M. Schkeryantz , Karin Worm , Rulin Ma , Patrick W. Papa

IPC分类号： C07D401/10 , C07D403/10 , C07D401/14

摘要： Provided herein are compounds and compositions thereof for modulating S1P5. In some embodiments, the compounds and compositions are provided for treatment of neurological diseases.

2.

发明公开
Carboxylic Acid Containing Indanyl Compounds for the Treatment of Neurodegenerative Diseases 审中-公开

公开(公告)号：US20240124394A1

公开(公告)日：2024-04-18

申请号：US18267551

申请日：2021-12-22

申请人： Celgene Corporation

发明人： Jeffrey M. Schkeryantz , Julie Selkirk , Philip Stewart Turnbull , Junko Tamiya , Patrick W. Papa , Jean-Francois Brazeau , Karin Worm

IPC分类号： C07D205/12 , A61P25/28 , C07D205/04 , C07D207/16 , C07D209/52 , C07D211/66 , C07D211/78 , C07D221/20 , C07D221/22 , C07D405/10 , C07D413/10

CPC分类号： C07D205/12 , A61P25/28 , C07D205/04 , C07D207/16 , C07D209/52 , C07D211/66 , C07D211/78 , C07D221/20 , C07D221/22 , C07D405/10 , C07D413/10

摘要： Provided herein are compounds and compositions thereof for modulating S1P5. In some embodiments, the compounds and compositions are provided for treatment of neurological diseases.

3.

发明公开
Carboxylic Acid Containing Azetidinyl Compounds for the Treatment of Neurodegenerative Diseases 审中-公开

公开(公告)号：US20240270714A1

公开(公告)日：2024-08-15

申请号：US18422500

申请日：2024-01-25

申请人： Celgene Corporation

发明人： Jeffrey M. Schkeryantz , Karin Worm , Rulin Ma , Patrick W. Papa

IPC分类号： C07D401/10 , C07D401/14 , C07D403/10

CPC分类号： C07D401/10 , C07D401/14 , C07D403/10

摘要： Provided herein are compounds and compositions thereof for modulating S1P5. In some embodiments, the compounds and compositions are provided for treatment of neurological diseases.

4.

发明授权
Carboxylic acid containing azetidinyl compounds for the treatment of neurodegenerative diseases 有权

公开(公告)号：US11919879B2

公开(公告)日：2024-03-05

申请号：US17840876

申请日：2022-06-15

申请人： Celgene Corporation

发明人： Jeffrey M. Schkeryantz , Karin Worm , Rulin Ma , Patrick W. Papa

IPC分类号： C07D401/10 , C07D401/14 , C07D403/10

CPC分类号： C07D401/10 , C07D401/14 , C07D403/10

摘要： Provided herein are compounds and compositions thereof for modulating S1P5. In some embodiments, the compounds and compositions are provided for treatment of neurological diseases.